SARS-CoV-2 IgM / IgG Antibody

Ibisobanuro bigufi:

Iki gikoresho kigenewe muri vitro yujuje ubuziranenge bwa antibody ya SARS-CoV-2 IgG mu ngero z’abantu za serumu / plasma, amaraso y’imitsi n’amaraso yintoki, harimo antibody ya SARS-CoV-2 IgG mu bantu banduye kandi bakingiwe inkingo.

Ohereza imeri kuri twe

Ibicuruzwa birambuye

Ibicuruzwa

Izina RY'IGICURUZWA

HWTS-RT090-SARS-CoV-2 IgM / IgG Igikoresho cyo Kumenya Antibody (Uburyo bwa zahabu ya Colloidal)

Icyemezo

Epidemiologiya

Indwara ya Coronavirus 2019 (COVID-19), ni umusonga uterwa no kwandura igitabo cyitwa coronavirus cyiswe Syndrome ya Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2).SARS-CoV-2 ni igitabo cyitwa coronavirus mu bwoko bwa muntu kandi muri rusange abantu barashobora kwanduzwa na SARS-CoV-2.Inkomoko nyamukuru yandura ni abarwayi ba COVID-19 bemejwe kandi batwara simptomatic ya SARS-CoV-2.Ukurikije iperereza ryakozwe muri iki gihe, igihe cyo gukora ni iminsi 1-14, cyane cyane iminsi 3-7.Ibyingenzi bigaragara ni umuriro, inkorora yumye, n'umunaniro.Umubare muto w'abarwayi uherekezwa no kuzunguruka mu mazuru, izuru ritemba, kubabara mu muhogo, myalgia na diyare.

Ibipimo bya tekiniki

Intego y'akarere	SARS-CoV-2 IgM / IgG Antibody
Ubushyuhe bwo kubika	4 ℃ -30 ℃
Ubwoko bw'icyitegererezo	Serumu yumuntu, plasma, maraso yimitsi namaraso yintoki
Ubuzima bwa Shelf	Amezi 24
Ibikoresho bifasha	Ntabwo bisabwa
Ibikoreshwa birenze	Ntabwo bisabwa
Igihe cyo kumenya	Iminota 10-15
Umwihariko	Nta reaction ihura na virusi, nka muntu coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, ibicurane by'ibicurane A (H1N1) (2009) virusi yibicurane bya H1N1 ibihe, H3N2, H5N1, H7N9, virusi ya grippe B Yamagata, Victoria, virusi yubuhumekero A na B, virusi ya parainfluenza 1,2,3, Rhinovirus A, B, C, ubwoko bwa adenovirus 1,2,3, 4,5,7,55.